Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 981 of 1,261
  1. US 7834041

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted
  2. US 7834185

    Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted
  3. US 7833968

    Pharmaceutical compositions for treating or preventing bone conditions

    The Regents of the University of California · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted
  4. US 7833722

    Ligands for G protein-coupled receptor protein and use thereof

    Takeda Pharmaceutical Company Limited · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted
  5. US 7833972

    Proteins and use thereof

    Takeda Pharmaceutical Company Limited · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted
  6. US 7834000

    CGRP receptor antagonists

    Vertex Pharmaceuticals Incorporated · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted
  7. US 7833789

    Monocyte cell

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted
  8. US 7834005

    Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted
  9. US 7834138

    Segmented polymers and their conjugates

    Nektar Therapeutics · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted
  10. US 7834037

    5-lipoxygenase-activating protein (FLAP) inhibitors

    AMIRA PHARMACEUTICALS, INC. · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted
  11. US 7834024

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted
  12. US 7834150

    Isolated cold-and-menthol-sensitive receptor (CMR1)

    The Regents of the University of California · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted
  13. US 7834088

    Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith

    Nektar Therapeutics · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted
  14. US 7834051

    Cyclic amine compounds

    Takeda Pharmaceutical Company Limited · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted
  15. US 7834200

    Processes and intermediates

    Vertex Pharmaceuticals Incorporated · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted
  16. US 7834035

    Allosteric modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted
  17. US 7833533

    Enhanced antiviral activity against foot and mouth disease

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted
  18. US 7829503

    Methods of identifying compounds that target tRNA splicing endonuclease and uses of said compounds as anti-fungal agents

    PTC THERAPEUTICS, INC. · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted
  19. US 7829533

    Cyclosporin analog formulations

    Isotechnika, Inc. · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted
  20. US 7829102

    Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted
  21. US 7829712

    Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase

    Xenon Pharmaceuticals Inc. · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted
  22. US 7829074

    Hydroxypatite-targeting poly(ethylene glycol) and related polymers

    Nektar Therapeutics · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted
  23. US 7829304

    Compounds and related methods for mutant p53 reactivation

    Northwestern University · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted
  24. US 7829688

    Peptides of CaV2.2 that inhibit pain

    The Board of Regents of the University of Texas System · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.